Article

  • The EMBO Journal (2000) 19, 4265 - 4271
  • doi:10.1093/emboj/19.16.4265

Dominant-negative activity of an alpha1B-adrenergic receptor signal-inactivating point mutation

Songhai Chen1, Fang Lin1, Ming Xu1, John Hwa2 and Robert M. Graham1,3

  1. Molecular Cardiology Unit, Victor Chang Cardiac Research Institute, St Vincent's Hospital, Sydney 2010, Australia
  2. Departments of Biology and Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
  3. School of Biochemistry and Molecular Genetics, University of New South Wales, Kensington, NSW 2033, Australia

Correspondence to:

Robert M. Graham, E-mail: b.graham@victorchang.unsw.edu.au

Received 23 May 2000; Accepted 23 June 2000; Revised 22 June 2000


alpha1-adrenergic receptors (alpha1-ARs) are members of the G-protein-coupled receptor (GPCR) superfamily and activate inositol phosphate (IP) turnover. We show that glycine and asparagine mutations of Phe303 in transmembrane segment VI (TMVI) of the alpha1B-AR, a highly conserved residue in GPCRs, although increasing agonist affinity, abolish agonist-activated IP signalling. Co-expression of the Phe303 mutants also inhibited (–)epinephrine-stimulated IP signalling by wild-type alpha1B-AR and other Gq-coupled receptors, as well as IP signalling mediated by AlF4- stimulation of both wild-type Gqalpha and a constitutively active mutant. The inability of the Phe303 mutants to signal is due to induction of a receptor conformation that dissociates G-protein binding from activation. As a result, the Phe303 mutants sequester Gqalpha and stoichiometrically inhibit Gq signalling in a dominant-negative manner. We further show that both the enhanced basal and agonist-stimulated IP-signalling activity of the constitutively active alpha1B-AR mutants, C128F and A293E, are inhibited in the double mutants, C128F/F303G and A293E/F303G. Phe303, therefore, appears to be critically involved in coupling TMVI alpha-helical movement, a key step in receptor activation, to activation of the cognate G-protein.

  • Keywords:

    • constitutive activity,
    • G-protein-coupled receptor,
    • inositol phosphate signalling